Duration of remission to ICI 182,780 compared to megestrol acetate in tamoxifen resistant breast cancer

J. F.R. Robertson*, A. Howell, D. J. De Friend, R. W. Blamey, P. Walton

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Duration of remission to ICI 182,780 compared to megestrol acetate in tamoxifen resistant breast cancer'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science